Siehe Firmendetails

BioNTech R&D (Austria) GmbH is a fully owned subsidiary of BioNTech SE and was previously called PhagoMed Biopharma GmbH. BioNTech R&D (Austria) focuses on the research and development of novel anti-bacterials including the development of synthetic lysins against chronic bacterial infections with high medical need.